nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—CYP2D6—Gefitinib—lung cancer	0.199	0.32	CbGbCtD
Alprenolol—CYP2D6—Vinorelbine—lung cancer	0.153	0.246	CbGbCtD
Alprenolol—CYP2D6—Erlotinib—lung cancer	0.118	0.189	CbGbCtD
Alprenolol—CYP2D6—Vinblastine—lung cancer	0.0943	0.152	CbGbCtD
Alprenolol—CYP2D6—Doxorubicin—lung cancer	0.058	0.0932	CbGbCtD
Alprenolol—Atenolol—ABCB1—lung cancer	0.00176	0.261	CrCbGaD
Alprenolol—Acebutolol—ABCB1—lung cancer	0.00162	0.241	CrCbGaD
Alprenolol—Metoprolol—ABCB1—lung cancer	0.00137	0.203	CrCbGaD
Alprenolol—Propranolol—CYP1A1—lung cancer	0.0013	0.193	CrCbGaD
Alprenolol—Propranolol—ABCB1—lung cancer	0.000692	0.103	CrCbGaD
Alprenolol—CYP2D6—Metabolism—ALDOA—lung cancer	0.000117	0.000314	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF1R—lung cancer	0.000117	0.000314	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CXCL8—lung cancer	0.000116	0.000313	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AVP—lung cancer	0.000116	0.000312	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PIK3CB—lung cancer	0.000116	0.000311	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HES1—lung cancer	0.000115	0.000308	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF1R—lung cancer	0.000114	0.000307	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CXCL8—lung cancer	0.000114	0.000306	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NCOA3—lung cancer	0.000113	0.000305	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—PIK3CA—lung cancer	0.000113	0.000303	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—RAF1—lung cancer	0.000112	0.000303	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MDM2—lung cancer	0.000112	0.000302	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HES1—lung cancer	0.000112	0.000302	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—RAF1—lung cancer	0.000112	0.000301	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF1R—lung cancer	0.000112	0.0003	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CXCL8—lung cancer	0.000111	0.000299	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—IL2—lung cancer	0.000111	0.000299	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ERBB2—lung cancer	0.000111	0.000298	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ADCY1—lung cancer	0.00011	0.000297	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ABCG2—lung cancer	0.00011	0.000297	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—RAF1—lung cancer	0.00011	0.000296	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PIK3CB—lung cancer	0.00011	0.000295	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HES1—lung cancer	0.00011	0.000295	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MTOR—lung cancer	0.000109	0.000294	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PIK3CB—lung cancer	0.000109	0.000294	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—IL2—lung cancer	0.000109	0.000292	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ENO2—lung cancer	0.000108	0.000291	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HPGDS—lung cancer	0.000108	0.000291	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—RAF1—lung cancer	0.000108	0.000289	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPP2R1B—lung cancer	0.000107	0.000289	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PIK3CB—lung cancer	0.000107	0.000289	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—IL2—lung cancer	0.000106	0.000286	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCL8—lung cancer	0.000105	0.000284	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PIK3CB—lung cancer	0.000105	0.000283	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCL8—lung cancer	0.000105	0.000283	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTT1—lung cancer	0.000105	0.000282	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ERBB3—lung cancer	0.000105	0.000282	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HRAS—lung cancer	0.000104	0.000281	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP2A6—lung cancer	0.000104	0.000279	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GCLC—lung cancer	0.000104	0.000279	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCL8—lung cancer	0.000103	0.000278	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ERBB3—lung cancer	0.000102	0.000276	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—AKT1—lung cancer	0.000101	0.000273	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCL8—lung cancer	0.000101	0.000272	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL2—lung cancer	0.000101	0.000271	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CASP3—lung cancer	0.0001	0.00027	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TERT—lung cancer	0.0001	0.00027	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL2—lung cancer	0.0001	0.00027	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ERBB3—lung cancer	0.0001	0.00027	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL6—lung cancer	9.98e-05	0.000269	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL2—lung cancer	9.86e-05	0.000265	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TERT—lung cancer	9.82e-05	0.000264	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ENO1—lung cancer	9.82e-05	0.000264	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCND1—lung cancer	9.78e-05	0.000263	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—JUN—lung cancer	9.76e-05	0.000263	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FGFR1—lung cancer	9.75e-05	0.000262	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL2—lung cancer	9.64e-05	0.000259	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TERT—lung cancer	9.61e-05	0.000259	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HIF1A—lung cancer	9.6e-05	0.000258	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FGFR1—lung cancer	9.54e-05	0.000257	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MMP9—lung cancer	9.49e-05	0.000256	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CDKN1A—lung cancer	9.46e-05	0.000255	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PTEN—lung cancer	9.44e-05	0.000254	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HIF1A—lung cancer	9.39e-05	0.000253	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FGFR1—lung cancer	9.33e-05	0.000251	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOA1—lung cancer	9.27e-05	0.000249	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—AKT1—lung cancer	9.21e-05	0.000248	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HIF1A—lung cancer	9.19e-05	0.000247	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—KDR—lung cancer	9.18e-05	0.000247	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOA1—lung cancer	9.07e-05	0.000244	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EP300—lung cancer	9e-05	0.000242	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—KDR—lung cancer	8.98e-05	0.000242	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOA1—lung cancer	8.86e-05	0.000239	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP2E1—lung cancer	8.81e-05	0.000237	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—KDR—lung cancer	8.79e-05	0.000236	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SRC—lung cancer	8.75e-05	0.000236	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NQO1—lung cancer	8.71e-05	0.000234	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—VEGFA—lung cancer	8.53e-05	0.000229	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—KIT—lung cancer	8.46e-05	0.000228	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3CG—lung cancer	8.46e-05	0.000228	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APC—lung cancer	8.46e-05	0.000228	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—NRAS—lung cancer	8.46e-05	0.000228	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—STAT3—lung cancer	8.44e-05	0.000227	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NRAS—lung cancer	8.42e-05	0.000227	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EGF—lung cancer	8.36e-05	0.000225	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—KIT—lung cancer	8.28e-05	0.000223	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APC—lung cancer	8.28e-05	0.000223	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3CG—lung cancer	8.28e-05	0.000223	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—NRAS—lung cancer	8.28e-05	0.000223	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EGF—lung cancer	8.18e-05	0.00022	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—MAPK3—lung cancer	8.1e-05	0.000218	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—KIT—lung cancer	8.09e-05	0.000218	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3CG—lung cancer	8.09e-05	0.000218	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APC—lung cancer	8.09e-05	0.000218	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—NRAS—lung cancer	8.09e-05	0.000218	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MAPK3—lung cancer	8.06e-05	0.000217	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—POMC—lung cancer	8.05e-05	0.000217	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EGF—lung cancer	8e-05	0.000215	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—BRAF—lung cancer	7.95e-05	0.000214	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—MAPK3—lung cancer	7.93e-05	0.000213	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—POMC—lung cancer	7.88e-05	0.000212	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6R—lung cancer	7.86e-05	0.000211	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—STK11—lung cancer	7.85e-05	0.000211	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CREBBP—lung cancer	7.84e-05	0.000211	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MYC—lung cancer	7.84e-05	0.000211	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—BRAF—lung cancer	7.78e-05	0.000209	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—MAPK3—lung cancer	7.75e-05	0.000209	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—EGFR—lung cancer	7.71e-05	0.000207	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—POMC—lung cancer	7.7e-05	0.000207	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6R—lung cancer	7.69e-05	0.000207	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CREBBP—lung cancer	7.67e-05	0.000207	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EGFR—lung cancer	7.67e-05	0.000206	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—BRAF—lung cancer	7.61e-05	0.000205	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—EGFR—lung cancer	7.54e-05	0.000203	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6R—lung cancer	7.51e-05	0.000202	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CREBBP—lung cancer	7.5e-05	0.000202	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAP2K1—lung cancer	7.49e-05	0.000202	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3CD—lung cancer	7.44e-05	0.0002	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—EGFR—lung cancer	7.37e-05	0.000198	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PIK3CA—lung cancer	7.37e-05	0.000198	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAP2K1—lung cancer	7.32e-05	0.000197	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—KRAS—lung cancer	7.28e-05	0.000196	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3CD—lung cancer	7.28e-05	0.000196	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTP1—lung cancer	7.26e-05	0.000196	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—KRAS—lung cancer	7.25e-05	0.000195	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PIK3CA—lung cancer	7.21e-05	0.000194	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAP2K1—lung cancer	7.16e-05	0.000193	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—KRAS—lung cancer	7.12e-05	0.000192	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3CD—lung cancer	7.11e-05	0.000191	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CAT—lung cancer	7.07e-05	0.00019	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PIK3CA—lung cancer	7.05e-05	0.00019	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—KRAS—lung cancer	6.97e-05	0.000187	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ABCB1—lung cancer	6.88e-05	0.000185	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TYMS—lung cancer	6.75e-05	0.000182	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	6.69e-05	0.00018	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTM1—lung cancer	6.68e-05	0.00018	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MDM2—lung cancer	6.66e-05	0.000179	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PIK3CA—lung cancer	6.66e-05	0.000179	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RAF1—lung cancer	6.64e-05	0.000179	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ERBB2—lung cancer	6.57e-05	0.000177	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	6.54e-05	0.000176	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MDM2—lung cancer	6.52e-05	0.000175	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RAF1—lung cancer	6.5e-05	0.000175	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3CB—lung cancer	6.48e-05	0.000174	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MTOR—lung cancer	6.48e-05	0.000174	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TP53—lung cancer	6.44e-05	0.000173	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ERBB2—lung cancer	6.43e-05	0.000173	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PIK3CA—lung cancer	6.4e-05	0.000172	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MDM2—lung cancer	6.37e-05	0.000172	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RAF1—lung cancer	6.35e-05	0.000171	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3CB—lung cancer	6.34e-05	0.000171	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MTOR—lung cancer	6.34e-05	0.000171	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP1A1—lung cancer	6.33e-05	0.00017	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ERBB2—lung cancer	6.28e-05	0.000169	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ERCC2—lung cancer	6.28e-05	0.000169	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCL8—lung cancer	6.23e-05	0.000168	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3CB—lung cancer	6.2e-05	0.000167	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MTOR—lung cancer	6.2e-05	0.000167	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HRAS—lung cancer	6.19e-05	0.000167	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HRAS—lung cancer	6.16e-05	0.000166	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCL8—lung cancer	6.09e-05	0.000164	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HRAS—lung cancer	6.06e-05	0.000163	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—AKT1—lung cancer	6.02e-05	0.000162	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CASP3—lung cancer	5.96e-05	0.00016	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCL8—lung cancer	5.96e-05	0.00016	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL2—lung cancer	5.95e-05	0.00016	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL6—lung cancer	5.92e-05	0.000159	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HRAS—lung cancer	5.92e-05	0.000159	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL6—lung cancer	5.9e-05	0.000159	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—AKT1—lung cancer	5.89e-05	0.000158	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CASP3—lung cancer	5.83e-05	0.000157	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL2—lung cancer	5.82e-05	0.000157	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCND1—lung cancer	5.8e-05	0.000156	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL6—lung cancer	5.8e-05	0.000156	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—JUN—lung cancer	5.79e-05	0.000156	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—AKT1—lung cancer	5.76e-05	0.000155	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CASP3—lung cancer	5.7e-05	0.000154	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL2—lung cancer	5.7e-05	0.000153	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCND1—lung cancer	5.68e-05	0.000153	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL6—lung cancer	5.67e-05	0.000153	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—JUN—lung cancer	5.67e-05	0.000152	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MMP9—lung cancer	5.64e-05	0.000152	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CDKN1A—lung cancer	5.62e-05	0.000151	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PTEN—lung cancer	5.6e-05	0.000151	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCND1—lung cancer	5.55e-05	0.000149	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—JUN—lung cancer	5.54e-05	0.000149	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MMP9—lung cancer	5.51e-05	0.000148	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CDKN1A—lung cancer	5.49e-05	0.000148	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PTEN—lung cancer	5.48e-05	0.000148	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—AKT1—lung cancer	5.47e-05	0.000147	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—AKT1—lung cancer	5.44e-05	0.000146	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOA1—lung cancer	5.43e-05	0.000146	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MMP9—lung cancer	5.39e-05	0.000145	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CDKN1A—lung cancer	5.37e-05	0.000145	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PTEN—lung cancer	5.36e-05	0.000144	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—AKT1—lung cancer	5.35e-05	0.000144	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EP300—lung cancer	5.34e-05	0.000144	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—AKT1—lung cancer	5.23e-05	0.000141	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EP300—lung cancer	5.23e-05	0.000141	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SRC—lung cancer	5.2e-05	0.00014	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EP300—lung cancer	5.11e-05	0.000138	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SRC—lung cancer	5.08e-05	0.000137	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—VEGFA—lung cancer	5.06e-05	0.000136	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—STAT3—lung cancer	5.01e-05	0.000135	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NRAS—lung cancer	5e-05	0.000135	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SRC—lung cancer	4.97e-05	0.000134	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3CG—lung cancer	4.96e-05	0.000133	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—VEGFA—lung cancer	4.95e-05	0.000133	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—STAT3—lung cancer	4.9e-05	0.000132	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NRAS—lung cancer	4.89e-05	0.000132	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—VEGFA—lung cancer	4.84e-05	0.00013	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—STAT3—lung cancer	4.79e-05	0.000129	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAPK3—lung cancer	4.79e-05	0.000129	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NRAS—lung cancer	4.78e-05	0.000129	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—POMC—lung cancer	4.72e-05	0.000127	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAPK3—lung cancer	4.68e-05	0.000126	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MYC—lung cancer	4.66e-05	0.000125	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CREBBP—lung cancer	4.6e-05	0.000124	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAPK3—lung cancer	4.58e-05	0.000123	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MYC—lung cancer	4.55e-05	0.000123	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EGFR—lung cancer	4.55e-05	0.000123	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EGFR—lung cancer	4.45e-05	0.00012	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MYC—lung cancer	4.45e-05	0.00012	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3CD—lung cancer	4.36e-05	0.000117	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EGFR—lung cancer	4.36e-05	0.000117	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—KRAS—lung cancer	4.3e-05	0.000116	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALB—lung cancer	4.3e-05	0.000116	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—KRAS—lung cancer	4.21e-05	0.000113	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—KRAS—lung cancer	4.11e-05	0.000111	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3CA—lung cancer	3.95e-05	0.000106	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3CA—lung cancer	3.87e-05	0.000104	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TP53—lung cancer	3.82e-05	0.000103	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3CB—lung cancer	3.8e-05	0.000102	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3CA—lung cancer	3.78e-05	0.000102	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS2—lung cancer	3.76e-05	0.000101	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TP53—lung cancer	3.74e-05	0.000101	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TP53—lung cancer	3.66e-05	9.84e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HRAS—lung cancer	3.66e-05	9.84e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HRAS—lung cancer	3.58e-05	9.63e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6—lung cancer	3.5e-05	9.42e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HRAS—lung cancer	3.5e-05	9.41e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6—lung cancer	3.42e-05	9.21e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6—lung cancer	3.35e-05	9.01e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTEN—lung cancer	3.28e-05	8.83e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AKT1—lung cancer	3.23e-05	8.69e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AKT1—lung cancer	3.16e-05	8.5e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—EP300—lung cancer	3.13e-05	8.42e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AKT1—lung cancer	3.09e-05	8.31e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3CA—lung cancer	2.32e-05	6.23e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—AKT1—lung cancer	1.89e-05	5.09e-05	CbGpPWpGaD
